Ginkgo Bioworks Holdings Inc (NYSE:DNA)
| 2.86 Delayed Data As of Jun 24 |  -0.08 / -2.72%Today’s Change | 2.09 Today|||52-Week Range 15.86 | -65.58% Year-to-Date |
Latest DNA News | Press Releases
No recent news for Ginkgo Bioworks Holdings Inc.
Today’s Trading
| Previous close | 2.94 |
| Today’s open | 3.00 |
| Day’s range | 2.76 - 3.12 |
| Volume | 43,592 |
| Average volume (3 months) | 21,764,469 |
| Market cap | $4.3B |
Data as of 4:01pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +53.54% |
| Earnings growth (next 5 years) | +44.09% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 42.67 |
| Price/Book | 3.06 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 17, 2022 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $313.8M |
| Annual profit (last year) | -$1.8B |
| Net profit margin | -583.12% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters --, -- |
Forecasts
